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Expression of and Genes Can Occur in all B Cells
and is Initiated Around the Same Pre-B-Cell
Developmental Stage
LYNN DOGLIO," JOO YEUN KIM, GRAZYNA BOZEK and URSULA STORBt
Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, Illinois 60637
Transgenic mice that carry a ,2 transgene under the control of the V2 promoter and the
E2-4 enhancer (,2E, mice) are described. A high proportion of B cells in the spleen and
the bone marrow express the transgene on the cell membrane. ,2 protein is synthesized
by all X2E-derived spleen B-cell hybridomas that have retained the transgene, suggesting
that all B cells have the ability to express genes. Feedback inhibition of endogenous c-gene
rearrangement is significant, but not complete. The results are similar to those with
transgenic mice expressing the same ,2 transgene under the control of the heavy-chain
enhancer (2EH mice). Although the X2EH transgene is expressed before the 2E,
transgene, feedback inhibition seems to occur at about the same stage of B-cell develop-
ment, regardless of the timing of expression of the , transgenes. Apparently, feedback is not
necessarily coincident with the assembly of a heavy-chain/light-chain complex in pre-B
cells. Expression of , in the normal fetal liver coincides with the expression of c; thus, it
appears that -gene transcription is not delayed. The differential rearrangement of c and ,
genes is discussed in the light of these findings.
KEYWORDS: c/ isotypic exclusion; mouse genes; feedback inhibition of Ig-gene rearrangement.
INTRODUCTION
Mammals produce both c and light chains but in
vastly different proportions. At one end of the
spectrum, mouse serum Igs are about 95% c+. At
the other end, horse Igs are 95% +, whereas human
light chains are divided between 60% c+ and 40%
,+ (Eisen and Reilly, 1985). It is not clear how these
ratios are regulated. Selection of c+ cells in the
peripheral lymphoid organs only partially explains
the skewing, because even in the bone marrow, c
cells outnumber + cells by at least 5:1 (this paper;
Rolink et al., 1993). Analysis of mouse and human
Ig producing lymphomas and plasmacytomas has
led to the hypothesis that c and , genes are
sequentially activated (Hieter et al., 1981). It was
found that most c-producing B cells have their ,
genes in germline configuration. In contrast, B cells
with functional , genes have, with few exceptions,
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both c genes rearranged or even deleted. The
sequential model postulated that developing B cells
would first acquire the ability to rearrange c genes. , genes would be activated only after both c genes
had been nonproductively rearranged. A modifica-
tion of this model is one in which the induction of
,-gene rearrangement requires the inactivation of
the c locus by rearrangement of the RS element
located 3’ of the Cc gene (Moore et al., 1985).
Recently, the sequential model, in which X rearrange-
ment depends upon prior events at the c locus, has
essentially been ruled out by the analysis of c
knockout mice, which, despite the absence of any
rearrangement in the c locus, produce large num-
bers of B cells with rearranged , genes (Takeda et
al., 1993).
The ordered rearrangement of Ig genes is con-
trolled by a V(D)J recombinase that is present in
pro/preB cells until correct heavy- and light-chain
gene rearrangements have occurred (reviewed in
Storb et al., 1989). It was shown with c transgenic
mice, that B cells that express the c transgene
together with an endogenous heavy-chain gene
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have their endogenous c genes mostly unrearranged
(Ritchie et al., 1984). This was taken as evidence for
the shutoff of the V(D)J recombinase after comple-
tion of correct rearrangements of both a heavy-
chain and a light-chain gene (Ritchie et al., 1984).
Similarly, it has been shown in mice that express a
X transgene under the control of the heavy-chain
enhancer that endogenous c-gene rearrangement is
strongly inhibited (Hagman et al., 1989; Neuberger
et al., 1989). Thus, it was clear that ,, presumably
the protein, can deliver a rearrangement feedback
signal.
A puzzling observation was the finding of normal
numbers of X-producing B cells in c transgenic mice,
while endogenous c-producing B cells were greatly
diminished (Gollahon et al., 1988). This led to the
hypothesis of two distinct B-cell populations with
different abilities to regulate c- and ,-gene expres-
sion. One, the c lineage, was thought to rearrange
only c genes, whereas the other, the c/, lineage,
was thought to be able to rearrange both c and ,
genes (Gollahon et al., 1988).
To test this model, it had to be determined
whether X genes can be expressed in all or in only
a subset of B cells (Cuisinier et al., 1992). The
enhancers driving -gene expression had for a long
time been elusive, because it was found that,
unlike heavy-chain and c genes, no enhancers
were present in the JC intron of X genes (Picard
and Schaffner 1984; Hagman et al. 1990). Re-
cently, two strong B-cell-specific enhancers were
found to be located 16 kb and 35 kb 3’ of the
C,2-4 and C,3-1 constant-region gene clusters,
respectively (Hagman et al., 1990). It was then
possible to make transgenic mice with transgenes
driven by the transcriptional control elements.
We report here the analysis of transgenic mice
with a rearranged 2 transgene under the control
of the V,2 promoter and the E,2-4 enhancer.
They were generated to determine if all B cells can
produce , and to obtain additional clues concern-
ing the control of the differential expression of c
and , genes.
RESULTS
Tissue-Specific Expression
Expression of the ,2E, transgenes was determined
by Northern blots of total RNAs from a variety of
tissues. It was found that the ,2E, transgene was
transcribed in the spleen, but not in thymus T cells
(some , mRNA was seen in thymus, but it was
matched by c mRNA from B-cell contamination),
liver, kidney and heart, suggesting that expression is
restricted to B cells (data not shown).
FACS Analysis of Spleen Cells
To determine the distribution of ,+ and c+ cells in
the peripheral lymphoid organs, spleen cells of ,2
transgenic mice and normal littermates were ana-
lyzed by fluorescence-activated cell sorter (FACS).
Total Ig
/ cells were determined by staining with
anti-c and anti-,. The average of total lymphoid
cells that are Ig was 59.2+5.2 for normal litter-
mates, for ,2E, transgenics it was 5.6 + 4 (X94 line)
and 36.6 + 4.8 (,96 line), and for ,2EH transgenics
it was 51.7 + 0.7.
Table 1 shows the percentages of , and c posi-
tive cells. Normal mice have on average only 14%
total ,+ cells, including half that are K+/c+. The
majority, 93%, of the B cells are c+. In the X2EX
transgenic mice on the other hand, on average
68% (,94) or 71% (,96) of the B cells are /. The
majority of these coexpress c (46% or 56%). Only
22% or 15% of the total B cells are X-only cells,
32% or 29% are c-only. Clearly, as has been
found previously with ,2EH-gene transgenic mice
(Hagman et al., 1989; Neuberger et al., 1989;
Rudin et al., 1991), there is feedback on endoge-
nous c-gene rearrangement, but it is incomplete.
No significant difference is seen between 94 and
96 ,2E, transgenic mice. The degree of feedback
in the ,2E mice seems very similar to that found
in the ,2EH mice: Both show a decrease in total c+
cells and a substantial population of ,-only cells.
However, in the mice with the ,2EH transgene
more of the c cells coexpress , (32% versus 16%).
Perhaps this is a reflection of the somewhat
greater amounts of protein on mature B cells of
these mice due to greater efficiency of the heavy-
chain enhancer at this stage. The total ,+ B cells
can be roughly divided into two populations based
on staining intensity with anti- (not shown). In
the ,2EH transgenic mice, 42% of the total ,+ B
cells express high levels of ,, however, only 31%
of the + cells in ,2E, mice fall in this category.
Why are not 100% of the B cells ,+? We assume
that this is due to our inability to detect low levels of , in many double-positive cells. This assumption is
supported by the analysis of hybridomas.L. DOGLIO et al 151
Exp. no. Mouse Age
(wk)
TABLE
FACS Analysis of Spleen Lymphoid Cells
% of Total Ig spleen lymphoid cellsb
only only Total Total
NLM-1 8 85 11 4 96 15
96-2 8 30 55 15 85 70
96-3 8 27 57 16 84 73
,EH-4 6 20 59 21 79 80
KEH-5 6 13 61 23 77 87
NLM-2 6 88 3 7 91 10
NLM-3 6 87 9 4 96 13
NLM-6 6 86 5 9 91 14
NLM-7 6 86 7 7 93 14
94-1 6 34 46 20 80 65
94-4 6 35 43 22 78 65
X94-5 6 34 43 23 77 66
NLM-22 6 82 9 9 91 18
NLM-23 6 86 7 8 93 15
94-16 6 31 46 23 77 69
94-17 6 25 51 23 76 74
Mean % + standard deviation
only :/ only Total : Total
NLM
n=7 86.0+2.0 7.0+2.3 7.0+1.8
94
n=5 31.8 + 4.0 45.8 + 3.0 22.0 + 1.3
96
n=2 28.5 + 2.1 56.0 + 1.4 15.3 +0.4
KEH
n=2 16.0 + 5.6 61.5 + 3.5 22.0 + 1.4
aNormal litermate (NLM) transgenic mice (94 and 96 2EK mice; ,EH K2EH mice). bTotal Ig determined by staining with anti-: anti-K antibodies.
93.0+2.0 14.0+2.6
77.6 + 1.5 67.8 + 3.8
84.5 + 0.7 71.0 + 1.4
78.0 + 1.4 83.5 + 4.9
Spleen B-Cell Hybridomas of g2Eg Transgenic
Mice
Hybridomas were produced from the spleens of
4-week-old LPS-treated 2E, transgenic mice. Of 67
hybridomas, 20 (30%) secreted c, 33 (49%) secreted
: and ,, and 14 (21%) secreted , only. These
percentages are very similar to those of Ig spleen
cells determined by FACS analysis (Table 1). A
subset of the hybridomas was further studied (Table
2). It was found that all the c-only hybridomas had
lost the transgenes. Similar results were found with
hybridomas of 2EH mice (Hagman el al., 1989).
Based on these findings, it appears that the ,2
transgene under the control of its own enhancer can
be expressed in all B cells. It is not clear whether
most of the :+ cells in the spleen (as determined by
FACS analysis) have also lost the transgene. The fact
that the percentages of :-only cells in spleen and
hybridomas agree so well may suggest that this is
the case. However, hybridomas are notorious for the
loss of chromosomes due to their polyploidy. It
appears more likely that the "K-only" B cells in the
spleen express the transgene, but that K has a
higher affinity for many heavy chains. It has been
shown that in a competitive situation, even a
slightly higher affinity of one type of light chain
with the heavy chain results in its preferential
association with the heavy chain (Grey and Mannik,
1965; Margulies et al., 1976; Klein et al., 1979).
All ,-only hybridomas show only germline :
genes. Of course, it cannot be ruled out that some of
them have lost a chromosome carrying a rearranged
c gene. However, in normal mice, only 60% of the
+ cells have retained one germline allele and
essentially none of the ,+ cells retain a germline c
allele (Coleclough et al., 1981). Thus, the , hybrid-
omas from these 2E, mice support the conclusion
from the FACS analysis that the X2E transgene
causes feedback inhibition of c-gene rearrangement.
On the other hand, only 30% of the double ://,+
hybridomas and none of the c hybridomas show a
germline c allele. Presumably, the c cells that have
a germline allele had produced a functional c
allele by rearrangement before expression of the16 LAMBDA TRANSGENIC MICE
TABLE 2
Hybridomas of 4-week-old 2E,-94 Transgenic Mice
Hybridoma’ ELiSA Transgene
b c’ genes jH 3,44 5’DH 5’JH H genesg
no.
5-2 D + R G 1B VDJ/DJ
5-3 D + R G 1B VDJ/DJ
5-13 D .+ G/R G G G VDJ/G
5-17 D + G G G VDJ/G
5-18 D + R/R 1B VDJ/DJ
5-20 D + G/R G 3B VDJ/DJ
5-40 D + G/R G 3B VDJ/DJ
5-45 D + G 1B VDJ/DJ
5-52 D + 1B VDJ/DJ
5-55 D + R R 1B VDJ/DJ
5-31 K R VDJ
5-39 K G G G VDJ/G
5-43 K R VDJ
5-49 K R VDJ
5-51 K R G VDJ
5-54 K R VDJ
5-6 L + G 1B VDJ/DJ
5-7 L + G 1B VDJ/DJ
5-10 L + G G G G G
5-11 L + G G G G G
5-14 L + G G 1B G G/DJ
5-25 L + G G 1B VDJ/DJ
5-26 L + G G G G G
5-38 L + G G -G G G
5-41 L + G G G G G
5-44 L + G G G G G
5-48 L + G G G G G
5-50 L + G G G G G
5-59 L + G G G G G
5-60. L + G G 3B VDJ/DJ
aELISA of the hybridoma secretions showed : and K(D), c(K), K (L) protein.
bpresence of the , transgene determined by Southern blot.
CRearrangement of endogenous genes determined from Southern blots of Barn HI-digested DNA probed first with C: probe and after stripping reprobed with
5’ of J:l probe. R rearranged gene. G=germline : gene. -=c gene is not present.
dH genes analyzed by digestion with Barn HI and probing with JH 3-4 probe (Manz et al., 1988). G=germline band; R--rearranged band; band detected
eDigestion with EcoRI and probing with 5’ DH probe (Manz et al., 1988) shows five bands if rearrangement has occurred (=G). DJ rearrangement generally leads
to reduction of the number of bands (1B, 3B=1 bands). ---VD rearrangement deletes all bands with this probe.
fDigestion with EcoRI and probing with 5’ JH (Manz et al., 1988) results in band only if DJ rearrangement has occurred (G).
gConclusion concerning the H-gene status. VDJ=heavy chains secreted. DJ=at least band is with the 5’ DH probe. G=band with the 5’ JH probe.
transgene led to feedback inhibition of the V(D)J
recombinase. Because the c-only and double c/
hybridomas have fewer germline c alleles than c
cells from normal mice, the parent B cells must have
been selectively enriched, presumably by antigen.
The presence of a band in Southern blots of DNA
hybridizing with a probe derived from a region 5’ of
JH1 indicates the presence of an unrearranged
heavy-chain allele (Alt et al., 1984). Many of the
hybridomas showed evidence of such a germline H
allele (Table 2). This was confirmed by the presence
of germline bands when the blots were probed with
a sequence from 5’ of DH (Table 2). The proportion
of hybridomas with germline heavy-chain alleles is
similar to that of hybridomas from ,2EH transgenic
mice (Hagman et al., 1989). Germline heavy-chain
alleles are very rare in hybridomas from normal
mice (Roth et al., 1993; Weaver et al., 1985). In
transgenic hybridomas that produce a heavy chain,
the presence of a germline H locus presumably
indicates that the productive heavy-chain gene re-
arrangement occurred in a pre-B cell already ex-
pressing the light-chain transgene and that the
V(D)J recombinase was inactivated before the sec-
ond heavy-chain allele could begin to rearrange.
Most of the ,-only hybridomas show only germ-
line heavy-chain genes with no evidence of any
heavy-chain gene rearrangement. Although many
of these may have lost one chromosome 12 carrying
the rearranged heavy-chain allele, it seems unlikely
that all of them did, particularly, given that all the
c+ and double-producing hybridomas show at least
one rearranegd heavy-chain allele. It appears then
that these mice may have some pre-B cells in the
spleen and that these cells can be readily fused with
myeloma cells. To a lesser degree, a similar findingL. DOGLIO et al 17
was made with hybridomas from 2EH mice
(Hagman et al., 1989). It is puzzling that in FACS
analysis, many more ,-only B cells were found than
+ hybridomas that have heavy chains. This has not
been further explored.
FACS Analysis of Bone Marrow B Cells
Because spleen B cells represent a population of
antigen-selected cells, we analyzed bone marrow
cells in order to evaluate the distribution of c and , cells that are largely unselected (Table 3). 33.9 to
51% of the total lymphoid cells in the bone mar-
row were Ig/. The averages were 43.5 +4.5 for
normal littermates, 47.2+4.5 (,94) and 34.3 +0.6
(,96) for ,2EK transgenics, and 40.6 + 1.5 for 2EH
transgenic mice. 17% of Ig bone marrow B cells
of normal littermates express X. This is slightly
higher than in spleen and persumably more
closely reflects the actual rate of , rearrangements
in the bone marrow as described before (Kim et
al., 1994).
In the , transgenic mice, an average of 51 to 69%
of the bone marrow B cells are ,+ (Table 3). In
contrast to the spleen (Table 1), in the bone marrow
of transgenic mice, more than 50% of ,+ cells
express only. However, the Z, transgenic mice also
have a higher percentage of c-only versus c/ B
cells. Does this mean that the endogenous c en-
hancer is active before the transgenic X enhancer?
This is unlikely given findings with fetal liver (see
what follows). Also in ,2EH transgenic mice, c-only
B cells exceed the number of c/, B cells. The basis
of these findings is not clear. Overall, similar pro-
portions of c and positive cells are found at 6
weeks of age in the bone marrow of both ,2E and
K2EH mice.
Compared with normal littermates, in , trans-
genic mice, regardless 6f the type of enhancer
present in the transgenes, the strongest" transgene-
induced effect in bone marrow cells is a reduction by
over 50% of the number of B220high/l
+ lymphoid
cells (Fig. 1). Thus, both types of transgenes induce
feedback inhibition of endogenous c-gene re-
arrangement, although the inhibition seems stron-
ger with the K2EH transgene (Fig. 1B). However,
B220w/c cells are present in very similar numbers
in normal and both types of , transgenic mice. The
TABLE 3
FACS Analysis of Bone Marrow Lymphoid Cells
Exp.
no.
Mouse Age % of Total Ig+ Cells
(wk) only :/ only Total Total
NLM-1 8 91 3 6 94 9
X96-2 8 50 25 24 75 49
96-3 8 48 24 28 72 52
XEH-4 6 31 18 51 49 69
,EH-5 6 29 19 52 48 71
NLM-2 6 81 4 15 85 19
NLM-3 6 87 5 8 92 13
NLM-6 6 74 14 12 89 26
,94-1 6 27 26 46 53 72
94-4 6 28 21 51 49 72
,94-5 6 23 21 55 44 76
NLM-22 6 87 3 10 90 13
NLM-23 6 87 4 8 91 13
X94-16 6 32 25 42 57 67
,94-17 6 ,35 24 36 59 60
Mean % + standard deviation
only / only Total Total
NLM
n=6 83.2 + 5.8 6.0 + 4.5 10.6 + 2.9
94
n=5 29.0 + 4.6 23.4 + 2.3 46.0 + 7.4
X96
n=2 49.0 + 1.4 24.5 + 0.7 26.0 + 2.8
EH
n-2 30.0 + 1.4 18.5 + 0.7 51.5 + 0.7
aNormal littermate (NLM) transgenic mice (,94 and 96 are K2E, mice; EH ,2EH mice).
89.2+2.8
52.8+5.7
73.5+2.1
48.7+0.7
16.8+5.7
68.8+7.7
51.0+1.4
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FIGURE 1A. FACS analysis of bone marrow lymphoid cells (A) and (B) are from different experiments.
reduction in :+ cells occurs, therefore, at the trans-
ition from B220w to B220high B cells.
Kappa and Lambda and mRNAs in Fetal Livers
In order to more directly determine the timing of
expression of the transgenes, fetal liver RNAs
were analyzed (Fig. 2). Expression of the X2EH
transgene is detectable in Northern blots in day 14
fetal livers and reaches a peak at day 15. Expression
of the X2EZ transgenes is seen at day 15 and reaches
a plateau at day 16 in Northern blots of fetal liver
RNA of 96 mice (Fig. 2A). In Northern blots of
RNA from 94 mice, the mature 2 mRNA signal isL. DOGLIO et al 19
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FIGURE lB. FACS analysis of bone marrow lymphoid cells. (A) and (B) are from,different experiments.
not seen until day 16, at which time peak levels are
present also in this mouse (Fig. 2A). This expression
pattern is confirmed by PCR of fetal liver RNAs
from X94 mice (data not shown). Presumably, the
overall levels are lower in ,94 compared with X96
due to the lower-transgene copy number. However,
the time course seems to be the same in both ,2E,
transgenic lines with peak levels being delayed by
about 1 day compared with the ,2EH transgenic
line. There seems to be a decline of , RNA levels for
both ,2E, transgenic lines at day 18, but not for the
,2EH line. Perhaps this is due to limiting amounts
of transcription factors shared between : and
genes, such as PU.1 (Eisenbeis et al., 1993). Com-20 LAMBDA TRANSENIC MICE
A
FIGURE 2. Analysis of , and c mRNAs in fetal liver of transgenic and normal mice. (A) Northern blots of fetal liver RNAs from
,2EH and ,2E, transgenic fetuses: top, X2; bottom, GAPDH. (B) PCR analysis of mature n; M, 2, 3 (,); and X1 mRNAs, as well as
ribosomal protein-17 mRNA of normal fetal livers. The mature transcripts are indicated by an arrow. Asterisks are unknown bands
that may represent DNA or urfspliced RNAs or priming in unrelated RNAs. The same two samples are shown for day 14 in the c
panel, with no blank lane in between. (C) PCR analysis of sterile transcripts in the same fetal liver RNAs as in (B). Reactions with
reverse transcriptase are shown on the left, and without reverse transcriptase on the right for the three assays 0c, V,, and C,1) in
which the amplified RNA transcripts are of the same size as amplified DNA. There is a background level of CM amplification without
reverse transcriptase, but the level with reverse transcriptase well exceeds it. The days of gestation are indicated (17 E, L day 17 early,
late).L. DOGLIO et al 21
petition may exist between endogenous K and/or
gene expression and the expression of the 2EX
transgenes. Because this seems not the case for the
heavy-chain enhancer, the latter factors may not be
limiting in the developing B cells.
To compare the timing of expression of endo-
genous : and , genes, fetal liver RNA from normal
mice was analyzed by PCR, because Northern blots
were found not to be sensitive enough. No evidence
for the expression of rearranged : and genes was
obtained at day 14, but the mature forms of both K
and , mRNAs were clearly present at day 15 (Fig.
2B). The mRNAs were.determined usingV and
C primers, which detect all three forms of ,mRNA
(V2JC2, V1JC3, and VIJC1; see Materials and
Methods). A similar profile of expression was seen
with VIJC1 specific primers (Fig. 2B). These data
suggest that competency for rearrangement and
expression of : and genes arise in parallel.
To further compare the activation of the K and ,
loci in developing B cells, sterile transcripts from the
two loci were analyzed (Fig 2C). Both :0 and C
transcripts were seen at day 14. The C transcripts
could be either germline or mature. However, be-
cause no mature , transcripts were found at day 14,
these must be sterile. Sterile C, transcripts have also
been seen in rat (Hellman et al., 1985). A spliced :0
transcript was also detectable at day 14. The latter
had previously been reported only in Abelson mur-
ine leukemia virus transformed pre-B cell lines
(Leclercq et al., 1989), but, as shown here, is also
present in normal pre-B cells. A sterile V, transcript
was not detectable until day 15 (Fig. 2C). Thus, it
seems that the appearance of mature , mRNA and
presumably rearrangement of genes does not
occur until the VX promoter is active. This cannot be
tested for : because no consensus sequence exists of
the region 3’ of V: genes.
DISCUSSION
The 2EK transgenes are expressed tissue specific-
ally, namely, only in B cells. They are thus similar in
expression to ,1 transgenes that contained a similar
length of sequence upstream of the V, promoter,
but included the complete sequences between C,1
and the EX3-1 enhancer (about 35 kb) and addi-
tional 10 kb 3’ of the enhancer (Eccles et al., 1990).
It appears from the findings with the2E trans-
genic mice that , genes can be expressed in most, if
not all B cells. Between 65% and 74% of spleen B
lymphocytes in these mice are ,+. This proportion
must be higher, considering that :/ coproducing B
cells may often not express the transgenic chain in
membrane Ig because of the competitive binding of
: with the heavy chain (Grey and Mannik, 1965;
Margulies et al., 1976; Klein et al., 1979). This is
confirmed by spleen B-cell hybridomas containing
the , transgene all of which secrete , light chains
(24/24). These results suggest that all B cells are
capable of expression. The data do not support a
model of a separate : B-cell lineage (Gollahon et al.,
1988). The implications for isotypic exclusion of :
and genes will be discussed below.
The transgenes containing the , enhancer lead
to significant feedback inhibition of :-gene re-
arrangement, very similar to that observed with the
2EH transgene (Tables 1 and 3; Hagman et al.,
1989). The percentage of newly synthesized :+ B
cells in the bone marrow is not significantly lower in
the 2EH transgenic mice compared with the ,2E,
mice. It is expected, and borne out by the RNA
analysis of fetal liver, that the , transgene with the
heavy-chain enhancer is expressed earlier than the
one with the enhancer, namely, at the time of the
earliest H-gene expression. One might have ex-
pected to see much stronger feedback on :-gene
rearrangement by the 2EH transgene, because the
transgenic light chain could associate with heavy
chains as soon as a functional heavy-chain gene is
created. The actual finding may indicate that feed-
back inhibition does not occur automatically after
heavy-chain/light-chain assembly. Rather, the pre-
B cells may have to reach a special stage in their
development and/or physically move to a particular
stromal cells compartment before feedback can en-
sue. The physiological stimulus for the feedback is
unknown, but in vitro experiments with N-myc
pre-B cells have suggested that the shutoff of the
V(D)J recombinase may require crosslinking of the
B-cell receptor (Ma et al., 1992). A similar conclusion
was drawn from studies with cultured pre-B cells
(Rolink et al., 1993) and with pre-T cells (Turka et
al., 1991).
The suggestion of delayed feedback is further
supported by the analysis of bone marrow B cells
expressing : and B220 (Fig. 1). In transgenic mice
with either the or heavy-chain enhancer, the
percentages of B2201w/:
+ cells are about the same
as in normal mice. However, the B220high/l+ cells
are reduced by 50% or more. This may indicate that
: rearrangement continues during the B220lw stage
and is only inhibited at the time when B cells22 LAMBDA TRANSGENIC MICE
that have productively rearranged a c gene transit
into the B220high stage. In that way, a large propor-
tion of newly arising B cells would coexpress endo-
genous c and transgenic X. Such a delayed feedback
may explain the production of endogenous light
chains replacing anti-self light chains in what has
been termed "receptor editing" (Tiegs et al., 1993).
It would also explain the escape of endogenous L
chain producing B cells from feedback inhibition by
rearranged c or transgenes (Manz et al., 1988;
Neuberger et al., 1989; Bogen and Weiss, 1991;
Rudin et al., 1991).
The development of expression of Ig genes in
fetal liver roughly parallels that of pre-B cells in the
bone marrow, but represents a synchronized popu-
lation of pre-B cells (Strasser et al., 1989). It is clear
from the Northern analysis that the expression of
the X2EH transgene precedes that of the ,2E,
transgene (Fig 2). Expression of the former, being
regulated by the heavy-chain enhancer, presumably
is simultaneous with t-gene expression in fetal mice
(Alt et al., 1981). Endogenous c- and -
gene
expression is seen as sterile transcripts as early as
day 14. Furthermore, mature c and , transcripts
indicative of gene rearrangement are seen by day 15
of gestation. There is therefore no indication that
the expression of c precedes that of ,.
If all B cells have the ability to rearrange both
classes of light-chain genes at the same time, why
then are less than 20% of the B cells arising in the
normal bone marrow expressing a gene? Because
the findings in K-knockout mice essentially refute a
model that explains c/X isotypic exclusion by mak-
ing , rearrangement dependent on a signal from the
c locus, it appears that the chance of rearrangement
for , is simply lower than for c. Stochastic models
have been considered a number of times (Cole-
clough, 1983); the question remains why has a
lower probability for rearrangement. The timing of
the expression of c and , genes seems to be similar
as shown by the findings with fetal liver RNAs (Fig
2). Additionally, pre-B cell lines have been found to
express reporter genes under the control of the ,
enhancer (C. Rudin, B. Kurtz and U.S., unpub-
lished). However, although , appears to be initially
expressed at the same time as c, the strength of
activation of the c and enhancers may be dif-
ferent. The c gene has two enhancers, whereas, due
to spatial constraints (Sto;b et al., 1989; Hagman et
al., 1990), each gene may be governed by only one
of the two , enhancers. Unlike the X enhancers, the
two c enhancers are controlled by different trans-
activating factors. Only the c intron enhancer is
activated by NFcB. Interestingly, the enhancers
have a certain homology with the 3’ c enhancer
(Pongubala et al., 1992; Eisenbeis et al., 1993). Thus,
the enhancers may compete with the 3’ c en-
hancer for the binding of the same transactivating
factors and the 3’ c enhancer may have a higher
binding affinity. To completely unravel the isotypic
exclusion of c and ,, the activation and relative
strengths of the c and , enhancers must be more
systematically analyzed once the transactivating
proteins are fully understood.
Another possibility to explain the c/X imbalance
is that the c and genes represent unequal targets
for the V(D)J recombinase (Miller et al., 1982). It has
been reported that in an in vitro system using
rearrangement constructs containing the c and
rearrangement signal sequences (RSS), the fre-
quency of c rearrangements is higher (Ramsden and
Wu, 1991). However, because rearrangement via the
X RSSs in this report was unphysiologically low (two
to three orders of magnitude lower than that via the
c RSSs), this claim must be evaluated by additional
experiments.
An important difference between the two loci are
the numbers of RSSs in V and J genes that can serve
as targets for rearrangement. The c locus has at least
50 V genes and 4 functional J genes (Tonegawa,
1983). The locus has only three V genes (V1, V2,
and Vx) and three functional J genes (J1, J2, and J3)
(Miller et al., 1988; Carson and Wu, 1989; Storb et
al., 1989). Thus, if the levels of V(D)J recombinase in
pre-B cells are limiting, c genes will have a much
greater chance for encounter with recombinase and
therefore rearrangement. Recent data with trans-
genic c-rearrangement substrates have ruled out a
mechanism in which the V(D)J recombinase would
bind to a single RSS as a holo-enzyme complex with
binding sites for both the 12-spacer RSS and the
23-spacer RSS and track to the nearest comple-
mentary RSS (Engler et al., 1993). The data are most
compatible with binding and random encounter of
at least two independent subunits, one with speci-
ficity for a 12-spacer RSS and the other for a
23-spacer RSS in a situation where the recombinase
is present in a limiting quantity. Nonsaturating
levels of the recombinase, at least at the stage of
L-gene rearrangement, are also supported by the
finding that about 60% of c B cells have one c
allele in germline conformation (Coleclough et al.,
1981). In this way, the problem of unequal levels of
c and , expression would be reduced to unequalL. DOGLIO et al 23
numbers of recombinase targets. The suggestion of
limiting recombinase levels will have to be tested.
Finally, the possibility of and c locus-specific
rearrangement coactivators (or silencers; Lauster et
al., 1993) that may exist in unequal concentrations
must be considered in future experiments.
MATERIALS AND METHODS
X2 Transgenes
Construction of the 2 transgene containing the
H-chain enhancer (,2EH) and the transgenic line
carrying this transgene (2-1275) have been de-
scribed (Hagman et al., 1989). A ,2 transgene
driven by the E2-4 enhancer was constructed as
follows (Fig. 3): The 1.6-kb Xhol-Sall fragment
containing the ,2 enhancer was isolated from pA16-
N16 (Hagman et al., 1990). This A16XS1.6 fragment
was then subcloned into the Sall site of X2-4.4X,
which contains the functionary rearranged ,2 gene
of the plamacytoma MOPC 315 (Wu et al., 1982;
Hagman, 1989; Hagman et al., 1989). The resulting
plasmid, 2EK, was digested with Sall and Pvul to
remove most of the vector, the insert was isolated
from Sea Plaque (FMC Corp., Rockland, ME) low-
melting agarose gels, and microinjected into the
pronucleus of C57BL/6J zygotes.
Transgenic Mice
Two X2EX transgenic lines were chosen for analysis.
One line, 2E-94, has 8-10 copies of the transgene,
and the other line, 2E-96, has approximately 50
copies.
REARRANGED X2 CONSTRUCTS
X2EH VJX2 EH CX2.. pUC19
FIGURE 3.
VJX,2 CX,?.. JX4 CX4 EX pUCl 9
The lambda transgenes. Top, K2EH; bottom, X2E,.
Hybridomas
2E-94 mice were injected with 20 tg of LPS in-
traperitoneally 3 days prior to fusion. Hybridomas
were generated as previously described (Manz et al.,
1988). Supernatants were screened for Ig L chains in
an ELISA assay, as described in detail elsewhere
(Hagman et al., 1989). Briefly, for kappa production,
goat anti-mouse (GAM)Ig (1:400; Kirkegaard& Perry
Laboratories, Gaithersburg, MD) was the solid-phase
antibody followed by peroxidase-conjugated GAMK
(1:1000; Southern Biotechnology Assoc., Birming-
ham, AL). Lambda L-chains were detected using a
combination of GAMX and peroxidase-conjugated
GAM (1/200 and 1/1000, respectively; Southern
Biotechnology Assoc.). In both assays, the TMB Mi-
crowell Peroxidase Substrate System (Kirkegaard &
Perry Laboratories) was used as the substrate. The
reaction was stopped with 1 M phosphoric acid and
the absorbance was read at 450 nm.
Nucleic Acid Procedures and Probes
DNA isolated from hybridomas or fetal tissue was
phenol/chloroform extracted using standard tech-
niques. Thirty micrograms of hybridoma DNA was
digested with Barn HI or Eco RI (New England
BioLabs, Beverly, MA), electrophoresed and blotted
to Gene Screen Plus (New England Nuclear, Bos-
ton). Hydridization and reprobing procedures have
been described (Manz et al., 1988).
RNA was isolated from the fetal liver of indi-
vidual embryos at 14 to 18 days gestation according
to the method of Chomczynski and Sacchi (1987).
Body DNA was also isolated to detemine which
embryos were transgenic.
Probes for Cc, pX2.1 JH4, 5’ of JH1, pDFL-2.7
(Manz et al., 1988) and C2 (Hagman et al., 1989)
have been described previously.
RNA Analysis by Northern Blots
Twenty micrograms of fetal liver RNA or 5 tg of
normal spleen RNA, as control, were analyzed by
Northern blot hybridization as described (Hagman
et al., 1989). 2 mRNA was detected by a 32p_
labeled C2 probe (Hagman et al., 1989). Under the
same condition, there was no detectable signal of
endogenous ,2/3 transcripts from nontransgenic
fetal liver RNA (not shown). The blots were re-
probed with a glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) probe (Fort et al., 1985).24 LAMBDA TRANSGENIC MICE
RNA PCR Analysis
The first strand of cDNA was synthesized from 5g
of total RNA using Avian Moloney Leukemia Virus
reverse transcriptase (15 U, Boehringer Mannheim)
in 20 tl of reaction mixture containing 50 mM Tris,
pH 8.5, 8 mM MgC12, 30 mM KC1, 1 mM DTT, 0.2
mM dNTPs (Pharmacia), RNasin (1 U/I, Promega),
random hexamer primer (20 pmoles, Pharmacia).
The reaction was carried out at 42C for 2 hours.
After heat denaturation at 65C for 15 min, 30 1 of
TE was added to the reaction mixture. Ten micro-
liters of the first-strand cDNA was amplified for
mature c or , transcripts, and 1 tl of the cDNA for
the control transcript (ribosomal protein-17 mRNA)
using the following primers: Vc degenerate primer
and Cc3 primer for c transcripts (product size of
695 bp), V,I and C2 primers for , transcripts (218
bp), V,I and C13 for ,1 transcripts (638 bp), RP17
primers for control transcripts (170 bp). For the
sterile transcripts that do not span introns, total
RNA was treated with RNase-free DNase
(Promega). Five micrograms of DNase-treated RNA
was used for the the cDNA synthesis as described
earlier, with and without reverse transcriptase in
parallel to make sure that the amplification occurs
from the cDNA templates. The following primer
pairs were used: Ko and Jc2 primers for the sterile c
transcripts (product size of 500 bp), Ko and Cc3 for
the spliced c transcripts (681 bp), VI and 3VM
primers for theV serile transcripts (262 bp), CM5
and CM3 for C1 transcripts (466 bp).
The PCR reaction mixture contained Taq buffer
(50 mM KC1, 10mM Tris, pH 8.3, 1.5 mM MgCI2,
0.01% (w/v) gelatin), 0.2 mM dNTPs, 1 U Taq
polymerase, 25 pmoles of primers, and cDNA tem-
plate in a volume of 25 1. Amplification was
performed using a Perkin Elmer Cetus GenesAmp
PCR System 9600 programmed for 30 cycles (28
cycles for the control transcript within the linear
range of amplification) of thermal denaturation (at
95C for 30 s), primer annealing (at 65C for 30 s),
and template extension (at 72C for 30 s). Ten
microliters of the amplified products were analyzed
by Southern blot hybridization using specific
probes:C probe for mature c transcripts, Jc2 probe
(Lewis et al., 1982) for sterile c transcripts, VM
probe for mature and sterile V, transcripts, and
C1 probe for C,1 transcripts.
The primers used were as follows: Vc degenerate
and Ko primers were described by Schlissel and
Baltimore (1989); Cc3 (3’ of poly A signal): 5’-
ACAGAGATCTCAAGTGCAAAGACTC-3’; VXI
(within hv2): 5’-AACCGAGCTCCAGGTGTTCCT-
GCCAGATT-3’; 3VM (60 bp 3’ of coding se-
quences): 5’-CCAAGCTTATGTAGCCACCTGTT-
AAGAAAGTGGTAG-3’; CM5 (5’ end of coding
sequences): 5’-GCAAGCTTAAGTCTTCGCCAT-
CAGTCACCCTGTTTCC-3’; C13 (3’ of poly A
signal): 5’-CTATTCTAGAATAACAGGTTGTGAA-
TGAAC-3’; C,2 (5’-GTGGACTTGGGCTGACC-
TGTG-3’, the C2 primer has homology to all three
C, sequences, but anneals preferentially to C,2/3);
RP17 upstream primer: 5’-TTTTACCAAGGACCC-
GCCAACATG-3’; RP17 downstream primer: 5’-
CTATCTTGTTGCGGAGCTTTTTGC-3’.
Flow Cytometry
Spleen and bone marrow cells were stained with
monoclonal antibodies as described (Hagman et al.,
1989) and analyzed by FACScan (Becton-
Dickinson). The following antibodies were used:
phycoerythrin (PE) conjugated rat anti-mouse c
(Becton-Dickinson); biotinylated rat anti-mouse
CD45R (clone RA3-6B2; PharMingen); and biotiny-
lated rat anti-mouse , (1+2) (clone R26-46;
PharMingen), detected by subsequent staining with
fluorescein isothiocynate (FITC)-conjugated strep-
tavidin (Jackson ImmunoResearch). Spleen and
bone marrow cells stained with anti-X (1+2) were
pretreated with purified rat anti-mouse Fcy II
receptor/CD32 (clone 2.4G2; PharMingen) at 0.6g
and 0.3 [.tg/106 cells, respectively. Unless otherwise
indicated, cells in the lymphocyte gate as defined by
forward light scatter were analyzed.
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